• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
XI Yinsheng,DAI Minyan,LI Xin.Preparation of compound methotrexate-aminophylline hydrogel and preliminary study on its pharmacodynamics[J].Journal Of Pharmaceutical Research,2026,45(7):742-751[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 906times   Download 555次 QR Code for this article
Scan with your phone!
复方甲氨蝶呤-氨茶碱水凝胶的制备及其药效学初步探究
奚寅生,代民言,李鑫
Font:Larger+|Default|Smaller-
(哈尔滨商业大学药学院,黑龙江 哈尔滨 150076)
摘要:
目的 确定复方甲氨蝶呤-氨茶碱水凝胶的制备工艺处方。并探究其对寻常型银屑病小鼠模型的治疗效果。方法 采用单因素与效应面(Box-Behnken)法优化制剂处方及工艺条件。将15只小鼠随机分为3组,其中一组不做处理为对照组,其他两组连续6 d 在左耳涂抹5%咪喹莫特(IMQ)乳膏建立银屑病样皮损模型,并分为以下组:对照组、银屑病模型组、复方甲氨蝶呤-氨茶碱水凝胶组。观察小鼠耳部皮损,记录耳部厚度变化,对耳部皮肤进行 HE 染色观察病理变化。采用Western检测耳部皮肤组织JAK1/STAT3/STAT5蛋白表达水平。结果 复方甲氨蝶呤-氨茶碱水凝胶最优处方工艺条件为:卡波姆940用量2.04%,丙二醇用量21.49%,氮酮用量2.85%,体系pH值为7.0。复方甲氨蝶呤-氨茶碱水凝胶组小鼠皮损明显减轻,左耳厚度降低,皮肤表皮厚度减小,耳部皮肤组织JAK1、STAT3、STAT5的蛋白相对表达量降低。结论 确定的水凝胶制备工艺相对简单、重复性良好。复方甲氨蝶呤-氨茶碱水凝胶对银屑病小鼠模型治疗效果良好,减轻皮肤炎症,发挥对银屑病的疗效。
关键词:  水凝胶  甲氨蝶呤  氨茶碱  银屑病模型  咪喹莫特诱导  药效学
DOI:10.13506/j.cnki.jpr.2026.07.004
基金项目:黑龙江省重点研发计划项目(No.2024ZX10B05)
Received Date:January 20, 2026   Revision Date:April 09, 2026   Publication Date:July 31, 2026
Preparation of compound methotrexate-aminophylline hydrogel and preliminary study on its pharmacodynamics
XI Yinsheng,DAI Minyan,LI Xin
(College of Pharmacy,Harbin University of Commerce,Harbin 150076,China)
Abstract:
Objective To optimize the formulation and preparation technology of compound methotrexate-aminophylline hydrogel, and explore its therapeutic effect on mice model of vulgaris psoriasis.Methods Single factor test and Box-Behnken response surface methodology were applied to optimize the formulation and preparation parameters. A total of 15 mice were randomly divided into three groups, among which one group was set as blank control group without any treatment. The other two groups were topically administrated with 5% imiquimod (IMQ) cream on the left ear for 6 consecutive days to establish psoriasis-like skin lesion models, namely psoriasis model group and compound methotrexate-aminophylline hydrogel treatment group. The ear skin lesions of mice were observed, and the changes in ear thickness were recorded. HE staining was performed to observe the pathological changes of ear skin and small intestinal tissues. Western blot was used to detect the protein expression levels of JAK1, STAT3 and STAT5 in ear skin tissues.Results The optimal formulation and preparation conditions of compound methotrexate-aminophylline hydrogel were as follows: Carbomer 940 2.04%, propylene glycol 21.49%, azone 2.85%, and the system pH was 7.0. In the compound methotrexate-aminophylline hydrogel group, the skin lesions of mice were significantly alleviated, the thickness of left ear and epidermal thickness were reduced, and the relative protein expression levels of JAK1, STAT3 and STAT5 in ear skin tissues were down-regulated.Conclusion The established hydrogel preparation process is relatively simple and demonstrates reproducibility.
Key words:  Hydrogel  Methotrexate  Aminophylline  Imiquimod-induced  Psoriasis model  Pharmacodynamics
Today's Visits:447    Total Visits:2383131
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.